Overview and Scope
Drug infusion systems are medical devices that are used to deliver medications and fluids into a patient’s body through a catheter or needle. Drug infusion systems are commonly used in hospitals, clinics, and other healthcare settings to administer medications, such as pain relief drugs, antibiotics, chemotherapy drugs, and fluids, to patients.
Sizing and Forecast
The drug infusion systems market size has grown strongly in recent years. It will grow from $12.8 billion in 2023 to $13.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to shift to electronic infusion devices, increased prevalence of chronic diseases, patient care advancements, home-based infusion therapy, expansion of ambulatory care settings.
The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $18.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to shift towards disposable systems, rising prevalence of chronic diseases, expansion of ambulatory care facilities, personalized medicine and adaptive dosing, increasing demand for home-based care. Major trends in the forecast period include wireless connectivity and remote monitoring, integration with electronic health records (ehr), smart pump technology, personalized and adaptive dosing, minimally invasive infusion techniques.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report
Segmentation & Regional Insights
The drug infusion systems market covered in this report is segmented –
1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users
North America was the largest region in the drug infusion systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of chronic diseases is expected to propel the growth of drug infusion system market going forward. Chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders often require long-term or continuous infusion therapy. Drug infusion systems offer a safe, efficient, and effective way to administer medication to patients with these conditions. Compared to high-income countries, prevalence has been increasing more quickly in low- and middle-income nations. Diabetes is a leading factor in renal failure, heart attacks, strokes, blindness, and lower limb amputation. According to the International Diabetes Federation (IDF), in 2021, 537 million adults aged in between 20-79 are living with diabetes (1 in 10 are suffering with diabetes) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Therefore, rise in demand increasing prevalence of chronic diseases drives the growth of the drug infusion system market.
Key Industry Players
Major companies operating in the drug infusion systems market report are Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Acromed AG, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc., Proteus Digital Health Inc., Pear Therapeutics Inc., Huma Inc.
The drug infusion systems market report table of contents includes:
1. Executive Summary
- Drug Infusion Systems Market Characteristics
- Drug Infusion Systems Market Trends And Strategies
- Drug Infusion Systems Market – Macro Economic Scenario
- Global Drug Infusion Systems Market Size and Growth
.
- Global Drug Infusion Systems Market Competitive Benchmarking
- Global Drug Infusion Systems Market Competitive Dashboard
- Key Mergers And Acquisitions In The Drug Infusion Systems Market
- Drug Infusion Systems Market Future Outlook and Potential Analysis
- Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
